Similar articles

• 4-1BB-mediated immunotherapy of rheumatoid arthritis.

  Seo SK, Choi JH, Kim YH, Kang WJ, Park HY, Suh JH, Choi BK, Vinay DS, Kwon BS. Seo SK, et al. Nat Med. 2004 Oct;10(10):1088-94. doi: 10.1038/nm1107. Epub 2004 Sep 26. Nat Med. 2004. PMID: 15448685
• Immunotherapy tackles lupus.

  Kammer GM. Kammer GM. Nat Med. 2002 Dec;8(12):1356-8. doi: 10.1038/nm1202-1356. Nat Med. 2002. PMID: 12457176 No abstract available.
• Immunotherapy with agonistic anti-CD137: two sides of a coin.

  Sun Y, Chen JH, Fu Y. Sun Y, et al. Cell Mol Immunol. 2004 Feb;1(1):31-6. Cell Mol Immunol. 2004. PMID: 16212918 Review.
• Impaired infiltration of tumor-specific cytolytic T cells in the absence of interferon-gamma despite their normal maturation in lymphoid organs during CD137 monoclonal antibody therapy.

  Wilcox RA, Flies DB, Wang H, Tamada K, Johnson AJ, Pease LR, Rodriguez M, Guo Y, Chen L. Wilcox RA, et al. Cancer Res. 2002 Aug 1;62(15):4413-8. Cancer Res. 2002. PMID: 12154048
• Modulation of the immune response through 4-1BB.

  Sica G, Chen L. Sica G, et al. Adv Exp Med Biol. 2000;465:355-62. doi: 10.1007/0-306-46817-4_30. Adv Exp Med Biol. 2000. PMID: 10810639 Review. No abstract available.